中药组分研究现状及相关思考  

Current Research Status and Relative Thinking on Traditional Chinese Medicine Components

作　　者：许钒 王运来 彭代银 Xu Fan;Wang Yunlai;Peng Daiyin(School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China)

机构地区：[1]安徽中医药大学药学院,合肥230012

出　　处：《世界科学技术-中医药现代化》2018年第2期163-168,共6页Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology

基　　金：国家自然科学基金委面上项目(81573720):基于肾病综合征模型及AVP-NOS/NO-AQP2途径研究当归芍药散活血利水作用机制及物质基础;负责人:许钒

摘　　要：中药组分研究是目前中药相关研究的热点,现在主要集中于两个方向:一是以原方的功效主治为基础,筛选能够体现原方性质的配伍组分,即组分中药;二是在原方化学成分群的基础上进行有序组合,筛选具有潜在临床疗效的新药物模式,即新的天然药物。本文通过回顾总结中药组分研究中的主要内容,并对多元化发展中的组分中药进行梳理分析,探讨中药组分与组分中药的研究模式,以期发掘具有一定价值的观点,为中药的深入研究提供参考。As traditional Chinese medicine（TCM） components have become a hotspot in the field of TCM study, there are two directions toward TCM components： based on original functions and indications screening for TCM components which could reflect the property of the original party compatibility; the second is to escape the original chemical composition based on a sequential combination to screen new drugs with potential clinical efficacy, called new natural medicine. This paper reviewed the relevant field study of TCM components and multi-component of TCM in order to explore their research patterns. The paper gave a certain value point in view of TCM components research and provided references for in-depth research of TCM.

关 键 词：中药组分 组分中药 组分配伍 天然药物 

分 类 号：R96[医药卫生—药理学]